Individuals with loss‐of‐function mutations in SCN9A exhibit congenital insensitivity to pain, while gain‐of‐function mutations cause chronic pain conditions such as paroxysmal extreme pain disorder and inherited erythromelalgia (IEM). The gene discussed is SCN9A; the disease is erythromelalgia.